156 related articles for article (PubMed ID: 29080118)
1. Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a Bayesian network meta-analysis of randomized controlled studies.
Jiang X; Shen W; Xu X; Shen X; Li Y; He Q
Clin Exp Nephrol; 2018 Jun; 22(3):562-569. PubMed ID: 29080118
[TBL] [Abstract][Full Text] [Related]
2. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Wong SC; Willis NS; Craig JC
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD003594. PubMed ID: 27726125
[TBL] [Abstract][Full Text] [Related]
3. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Willis NS; Craig JC
Cochrane Database Syst Rev; 2010 Nov; (11):CD003594. PubMed ID: 21069676
[TBL] [Abstract][Full Text] [Related]
4. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Habashy D; Hodson E; Craig J
Cochrane Database Syst Rev; 2004; (2):CD003594. PubMed ID: 15106208
[TBL] [Abstract][Full Text] [Related]
5. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
Hodson EM; Habashy D; Craig JC
Cochrane Database Syst Rev; 2006 Apr; (2):CD003594. PubMed ID: 16625586
[TBL] [Abstract][Full Text] [Related]
6. Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis.
Fu HD; Qian GL; Jiang ZY
J Investig Med; 2017 Jan; 65(1):65-71. PubMed ID: 27489255
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of cyclosporine a for patients with steroid-resistant nephrotic syndrome: a meta-analysis.
Li HY; Zhang X; Zhou T; Zhong Z; Zhong H
BMC Nephrol; 2019 Oct; 20(1):384. PubMed ID: 31646979
[TBL] [Abstract][Full Text] [Related]
8. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A; Sinha A; Gupta A; Kanitkar M; Sreenivas V; Sharma J; Mantan M; Agarwal I; Dinda AK; Hari P; Bagga A
Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
10. Interventions for steroid-resistant nephrotic syndrome: a systematic review.
Habashy D; Hodson EM; Craig JC
Pediatr Nephrol; 2003 Sep; 18(9):906-12. PubMed ID: 12836096
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of immunosuppressive medications for steroid-resistant nephrotic syndrome in children: a systematic review and network meta-analysis.
Li S; Yang H; Guo P; Ao X; Wan J; Li Q; Tan L
Oncotarget; 2017 Sep; 8(42):73050-73062. PubMed ID: 29069848
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of cyclosporine A in treatment of refractory nephrotic syndrome in children: a systematic review of randomized controlled trials].
Chen LZ; Jiang XY; Lu HY; Zhang QL; Mo Y
Zhonghua Er Ke Za Zhi; 2009 Dec; 47(12):898-903. PubMed ID: 20193140
[TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.
Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D
PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X; Li H; Ye H; Li Q; He X; Zhang X; Chen Y; Han F; He Q; Wang H; Chen J
Am J Kidney Dis; 2009 Jul; 54(1):51-8. PubMed ID: 19406543
[TBL] [Abstract][Full Text] [Related]
15. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
Lee YH; Song GG
Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of 13 immunosuppressive agents for idiopathic membranous nephropathy in adults with nephrotic syndrome: a systematic review and network meta-analysis.
Zheng Q; Yang H; Liu W; Sun W; Zhao Q; Zhang X; Jin H; Sun L
BMJ Open; 2019 Sep; 9(9):e030919. PubMed ID: 31511292
[TBL] [Abstract][Full Text] [Related]
17. Therapies for steroid-resistant nephrotic syndrome.
Hodson EM; Craig JC
Pediatr Nephrol; 2008 Sep; 23(9):1391-4. PubMed ID: 18368428
[TBL] [Abstract][Full Text] [Related]
18. A new 'tac' for childhood nephrotic syndrome.
Becknell B; Greenbaum LA; Smoyer WE
Kidney Int; 2012 Nov; 82(10):1049-51. PubMed ID: 23128115
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
Sinha A; Gupta A; Kalaivani M; Hari P; Dinda AK; Bagga A
Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
[TBL] [Abstract][Full Text] [Related]
20. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing.
Wu B; Mao J; Shen H; Fu H; Wang J; Liu A; Gu W; Shu Q; Du L
Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
